
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 1.070 | 3.290 | 2.220 |
Shares | 98.930 | 98.930 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 14.413 | 16.924 |
Price to Book | 2.801 | 2.774 |
Price to Sales | 2.413 | 2.172 |
Price to Cash Flow | 8.942 | 10.634 |
Dividend Yield | 2.780 | 2.765 |
5 Years Earnings Growth | 10.013 | 11.997 |
Name | Net % | Category Average |
---|---|---|
Technology | 17.570 | 20.629 |
Financial Services | 16.990 | 20.303 |
Healthcare | 16.320 | 12.025 |
Industrials | 16.100 | 14.181 |
Consumer Defensive | 10.550 | 7.912 |
Consumer Cyclical | 8.420 | 12.082 |
Communication Services | 4.620 | 9.280 |
Basic Materials | 4.390 | 9.122 |
Energy | 3.560 | 8.241 |
Utilities | 0.910 | 5.579 |
Real Estate | 0.580 | 4.472 |
Number of long holdings: 381
Number of short holdings: 23
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Amgen Inc | - | 1.04 | - | - | |
Novartis | CH0012005267 | 1.04 | 101.54 | +0.38% | |
Taiwan Semiconductor Manufacturing Co Ltd ADR | - | 1.03 | - | - | |
eBay Inc | - | 1.03 | - | - | |
Astellas Pharma Inc. | JP3942400007 | 1.02 | 1,661.0 | +1.06% | |
Intel Corp | - | 1.00 | - | - | |
Pfizer Inc | - | 0.93 | - | - | |
Roche Holding Participation | CH0012032048 | 0.89 | 260.20 | -0.04% | |
Qualcomm Inc | - | 0.87 | - | - | |
Merck & Co Inc | - | 0.87 | - | - |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Schroder FrontierMarketsEqA Acc SEK | 735.79M | -6.59 | 13.63 | 7.84 | ||
Schroder QEP GlblQulity C Acc SEK H | 591M | 8.03 | 11.02 | - | ||
Schroder ISF Japanese opp A Acc SEK | 51.58B | 0.30 | 10.79 | 8.25 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review